Effects of Denosumab on the Pharmacokinetics of Etanercept

Summary

The primary objective of the study was to characterize the effects of a single dose of denosumab on the pharmacokinetics (PK) of etanercept in postmenopausal women with low bone mineral density (BMD) and rheumatoid arthritis based on area under the serum concentration-time curve (AUC) and maximum observed serum concentration (Cmax).

Timeline

Start

2011-03

Primary completion

2016-01

Completion

2016-01

Drugs

Indications